FDA panel calls for more testing of diabetes drugs
The U.S Food and Drug Administration adviser on Wednesday said that Drugs designed to control type 2 diabetes should be subjected to more through safety reviews to ensure they don’t raise the risk of heart problems.The panel of outside experts voted 14-to-2, at the end of a two-day meeting, to recommend that all makers of [...]
